Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false
creator	label
publisher	pref label
tabling member	label

Search

1111101

	human indexable
	published
	registered interest
	answer date	15/04/2019
	date	10/04/2019
	date tabled	10/04/2019
	ddp created	10/04/2019 19:35:03
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	10/04/2019 20:18:13 17/04/2019 12:27:19
	hansard heading	Cannabis: Medical Treatments
	house id	1
	identifier	243361
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	17/04/2019 11:49:19
	question text	To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the number of NHS prescriptions for medicine in which THC is the dominant ingredient.
	session	2017/19
	session number	1
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2017/19 243361
	type	WrittenParliamentaryQuestion
	uin	243361
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259 pref label House of Commons
	tabling member	1436 label Biography information for Paul Farrelly

1111106

	human indexable
	published
	registered interest
	answer date	15/04/2019
	date	10/04/2019
	date tabled	10/04/2019
	ddp created	10/04/2019 19:35:25
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	10/04/2019 20:38:07 17/04/2019 13:06:09
	hansard heading	Cannabis: Medical Treatments
	house id	1
	identifier	243575
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	17/04/2019 12:26:52
	question text	To ask the Secretary of State for Health and Social Care, what advice has been issued to Clinical Commissioning Groups on the criteria for the prescription of medicinal cannabis.
	session	2017/19
	session number	1
	tabling member constituency	Leigh
	tabling member printed	Jo Platt
	title	House of Commons Tabled Parliamentary Question 2017/19 243575
	type	WrittenParliamentaryQuestion
	uin	243575
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4673 label Biography information for Jo Platt
	publisher	25259 pref label House of Commons
	tabling member	4673 label Biography information for Jo Platt

1111114

	human indexable
	published
	registered interest
	answer date	15/04/2019
	date	10/04/2019
	date tabled	10/04/2019
	ddp created	10/04/2019 19:43:41
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	10/04/2019 20:49:30 15/04/2019 15:00:17
	hansard heading	Hormone Pregnancy Tests Expert Working Group
	house id	1
	identifier	243383
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/04/2019 14:23:24
	question text	To ask the Secretary of State for Health and Social Care, what the criteria were for selecting members of the Expert Working Group for Hormone Pregnancy Tests.
	session	2017/19
	session number	1
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	title	House of Commons Tabled Parliamentary Question 2017/19 243383
	type	WrittenParliamentaryQuestion
	uin	243383
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	3924 label Biography information for Yasmin Qureshi
	publisher	25259 pref label House of Commons
	tabling member	3924 label Biography information for Yasmin Qureshi

1111113

	human indexable
	published
	registered interest
	answer date	15/04/2019
	date	10/04/2019
	date tabled	10/04/2019
	ddp created	10/04/2019 19:43:38
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	10/04/2019 20:49:26 15/04/2019 15:00:18
	hansard heading	Pregnancy Tests
	house id	1
	identifier	243382
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/04/2019 14:23:24
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 April 2019 to Question 239926 on Pregnancy Tests, for what reason previous studies were not considered robust; and what the extensive limitations were.
	session	2017/19
	session number	1
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	title	House of Commons Tabled Parliamentary Question 2017/19 243382
	type	WrittenParliamentaryQuestion
	uin	243382
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	3924 label Biography information for Yasmin Qureshi
	publisher	25259 pref label House of Commons
	tabling member	3924 label Biography information for Yasmin Qureshi